Precision Optics Corp Inc(POCI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.64 | Insider Own | 27.46% | Shs Outstand | 10.9M | Perf Week | -1.35% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | 2.17% | Shs Float | 7.9M | Perf Month | 3.54% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.06 | Inst Own | 33.41% | Short Float | 0.23% | Perf Quarter | -22.3% |
| Income | -0.00B | P/S | 1.66 | EPS this Y | - | Inst Trans | -2.91% | Short Ratio | 0.48 | Perf Half Y | -0.45% |
| Sales | 0.03B | P/B | 2.39 | EPS next 5Y | - | ROA | -18.49% | Short Interest | 0.02M | Perf YTD | 4.9% |
| Book/sh | 1.84 | P/C | 4.5 | EPS past 3/5Y | -69.34% -20.93% | ROE | -29.62% | 52W High | -28.62% ($6.15) | Perf Year | 1.94% |
| Cash/sh | 0.98 | P/FCF | - | Sales past 3/5Y | 6.79% 13.98% | ROIC | -20.98% | 52W Low | 23.66% ($3.55) | Perf 3Y | -29.29% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 28.9% | Gross Margin | 13.85% | Volatility(W/M) | 5.01% 6.31% | Perf 5Y | -20.9% |
| Dividend TTM | - | EV/Sales | 1.44 | Sales Y/Y TTM | 64.18% | Oper. Margin | -16.44% | ATR (14) | 0.25 | Perf 10Y | 109.05% |
| Dividend Ex-Date | - | Quick Ratio | 1.74 | EPS Q/Q | 95.41% | Profit Margin | -17.03% | RSI (14) | 50.02 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.1 | Sales Q/Q | 108.04% | SMA20 | 0.47% ($4.37) | Beta | 0.33 | Target Price | $8 |
| Payout | - | Debt/Eq | 0.21 | Earnings | 2026/5/13 | SMA50 | -1.2% ($4.44) | Rel Volume | 1.28 | Prev Close | $4.35 |
| Employees | 90 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | - | SMA200 | -4.48% ($4.6) | Avg Volume(3M) | 0.04M | Price | $4.39 |
| IPO | 1992/1/16 | Option/Short | No/Yes | Trades | 263 | Volume | 49,055 | Change | 0.92% |
Company
POCI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 Precision Optics () is a company that designs and manufactures ultra-compact optical components for medical endoscopes and single-use endoscope assemblies. Leveraging its expertise in microscopes and optical systems, the company is a primary supplier of single-use endoscopes for cystoscopy procedures.
Over the past 1 year, roughly in the middle
29% below its 1-year high.
POCI has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -29.3% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 33.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IWC 0.00%
VTI 0.00%
VXF 0.00%It ranks #4 in the industry
Based on market cap of $48M.
POCI $48M PER -
ISRG $127B PER 41.3
BDX $48B PER 53.2
MDLN $43B PER 38.0
FAQ
What kind of company is POCI?
POCI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of POCI?
The market cap of POCI is approximately $48M, ranking 4,958 within its sector.
What is the 52-week high and low for POCI?
POCI has recorded a 52-week high of $6.15 and a low of $3.55.
